300003SZSE
🚨 Material Event

2026 Semi-Annual Report

✨ AI Summary

Lepu Medical (Beijing) Co., Ltd. has released its 2026 semi-annual report. The board of directors and senior management confirm the accuracy and completeness of the financial information provided. The company has proposed a profit distribution plan based on a total share capital of 1,843,424,716 shares, offering a cash dividend of 1.6275 RMB (tax inclusive) per 10 shares to all shareholders.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Section I Important Notices, Table of Contents, and Definitions

The Board of Directors, the Board of Supervisors, and the directors, supervisors, and senior management of the Company guarantee that the information in this semi-annual report is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions. They assume individual and joint legal responsibility for the accuracy, truthfulness, and completeness of the contents.

Company head Pu Zhongjie, the person in charge of accounting work Wang Yong, and the head of the accounting department (accounting supervisor) Li Yun declare: We guarantee the truth, accuracy, and completeness of the financial report in this semi-annual report.

All directors have attended the board meeting to review this semi-annual report. Investors are advised to read the relevant content regarding the company's risk warnings in Section III, "Management Discussion and Analysis," Item 10, "Risks Faced by the Company and Countermeasures."

The profit distribution plan reviewed and approved by the Board of Directors is as follows: Based on 1,843,424,716 shares, a cash dividend of 1.6275 RMB (tax inclusive) will be distributed for every 10 shares to all shareholders. No bonus shares will be issued, and no capital reserve will be converted into share capital.

Table of Contents

Section I Important Notices, Table of Contents, and Definitions 2

Section II Company Profile and Key Financial Indicators 6

Section III Management Discussion and Analysis 9

Section IV Corporate Governance, Environment, and Social Responsibility 47

Section V Significant Events 50

Section VI Changes in Shares and Shareholders 55

Section VII Information on Bonds 61

Section VIII Financial Report 66

List of Documents Available for Inspection

  1. The original 2026 semi-annual report and summary signed by the Company's legal representative, Mr. Pu Zhongjie;

  2. The original financial statements signed and stamped by the Company's head, Mr. Pu Zhongjie, the person in charge of accounting work, Ms. Wang Yong, and the head of the accounting department, Ms. Li Yun;

  3. The originals of all company documents and announcements publicly disclosed on the website designated by the CSRC during the reporting period;

  4. Other relevant materials;

  5. Location for inspection of the above documents: The Company's Board Office.

Definitions

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.